Clinical review report: Iron isomaltoside 1000 (Monoferric) (Pharmacosmos A/S) indication: for the treatment of iron deficiency anemia in adult patients who have intolerance or unresponsiveness to oral iron therapy

The objective of this review was to perform a systematic review of the beneficial and harmful effects of iron isomaltoside 1000 injection (100 mg elemental iron/ml) for the treatment of iron deficiency anemia in adults (greater than/equal to 18 years of age) who have an intolerance or unresponsivene...

Full description

Bibliographic Details

Corporate Author:	Canadian Agency for Drugs and Technologies in Health
Format:	eBook
Language:	English
Published:	Ottawa (ON) CADTH 2020, May 2020
Edition:	Final
Series:	CADTH common drug review
Subjects:	Disaccharides / Therapeutic Use Adult Canada Anemia, Iron-deficiency / Drug Therapy Ferric Compounds / Therapeutic Use Treatment Outcome
Online Access:	http://www.ncbi.nlm.nih.gov/books/NBK564268
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa